182781842	182781842	CD	B-NP	O
|	|	NNP	I-NP	O
KPMMCO	KPMMCO	NNP	I-NP	O
|	|	VBD	B-VP	O
49695934	49695934	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0238686	0238686	CD	B-NP	O
|	|	CC	I-NP	O
10/12/2005	10/12/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/11/2005	10/11/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/30/2005	4/30/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
SAMU	SAMU	NNP	B-NP	O
,	,	,	O	O
CURTIS	CURTIS	NNP	B-NP	O
550-19-26-3	550-19-26-3	CD	I-NP	O
Beth	Beth	NNP	I-NP	O
Ba	Ba	NNP	I-NP	O
Ri	Ri	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/13/05	1/13/05	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TIMBERLAKE	TIMBERLAKE	NNP	B-NP	O
,	,	,	O	O
MEL	MEL	NNP	B-NP	O
WYATT	WYATT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Assisted	Assist	VBN	B-VP	O
Living	Live	VBG	B-VP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/21/05	10/21/05	CD	B-NP	O
by	by	IN	B-PP	O
THEUNISSEN	THEUNISSEN	NNP	B-NP	O
,	,	,	O	O
LYNWOOD	LYNWOOD	NNP	B-NP	O
D.	D.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
30990956	30990956	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/1/05	1/1/05	CD	B-NP	O
by	by	IN	B-PP	O
BOURNS	BOURNS	NN	B-NP	O
,	,	,	O	O
WALTON	WALTON	NNP	B-NP	O
JERALD	JERALD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
86899543	86899543	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIGOXIN	DIGOXIN	NN	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/1/05	1/1/05	CD	B-NP	O
by	by	IN	B-PP	O
CHRISTOFFERSE	CHRISTOFFERSE	NNP	B-NP	O
,	,	,	O	O
KRIS	KRIS	NNP	B-NP	O
MARCELLUS	MARCELLUS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOTHYROXINE	LEVOTHYROXINE	NN	B-NP	B-protein
SODIUM	SODIUM	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
05958677	05958677	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
MOTRIN	MOTRIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
IBUPROFEN	IBUPROFEN	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
600	600	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q8H	Q8H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2/14	2/14	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
75	75	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/21/05	10/21/05	CD	B-NP	O
by	by	IN	B-PP	O
CONNELLY	CONNELLY	NNP	B-NP	O
,	,	,	O	O
ELIAS	ELIAS	NNP	B-NP	O
E.	E.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
30990956	30990956	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/1/05	1/1/05	CD	B-NP	O
by	by	IN	B-PP	O
ORMONDE	ORMONDE	NNP	B-NP	O
,	,	,	O	O
GUY	GUY	NNP	B-NP	O
NICHOLAS	NICHOLAS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
DIGOXIN	DIGOXIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
REGLAN	REGLAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOCLOPRAMIDE	METOCLOPRAMIDE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
AC	AC	NN	I-NP	O
SIMETHICONE	SIMETHICONE	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QID	QID	NN	I-NP	O
VITAMIN	VITAMIN	NN	I-NP	O
B1	B1	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THIAMINE	THIAMINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
TRAZODONE	TRAZODONE	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
HS	HS	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/21/05	10/21/05	CD	B-NP	O
by	by	IN	B-PP	O
MORKVE	MORKVE	NNP	B-NP	O
,	,	,	O	O
OLLIE	OLLIE	NNP	B-NP	O
J.	J.	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MVI	MVI	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/1/05	1/1/05	CD	B-NP	O
by	by	IN	B-PP	O
MUNGO	MUNGO	NNP	B-NP	O
,	,	,	O	O
KOREY	KOREY	NNP	B-NP	O
DEON	DEON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
GABAPENTIN	GABAPENTIN	NN	I-NP	O
200	200	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
TORSEMIDE	TORSEMIDE	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
COZAAR	COZAAR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LOSARTAN	LOSARTAN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
LEVOCARNITINE	LEVOCARNITINE	NN	I-NP	O
1	1	CD	I-NP	O
GM	GM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/24	4/24	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
15	15	CD	B-NP	O
ml	ml	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
20	20	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ADVAIR	ADVAIR	NNP	I-NP	O
DISKUS	DISKUS	NNP	I-NP	O
250/50	250/50	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/1/05	1/1/05	CD	B-NP	O
by	by	IN	B-PP	O
WHITESELL	WHITESELL	NNP	B-NP	O
,	,	,	O	O
OTIS	OTIS	NNP	B-NP	O
DARRICK	DARRICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NEXIUM	NEXIUM	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/21/05	10/21/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
you	you	PRP	B-NP	O
Primary	Primary	NNP	B-NP	O
Care	Care	NNP	I-NP	O
Provider	Provider	NNP	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
6/25/05	6/25/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Hechinger	Hechinger	NNP	I-NP	O
AH	AH	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
SHRIMP	SHRIMP	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Adriamycin	Adriamycin	NN	I-NP	O
induced	induce	VBD	B-VP	O
CMP	CMP	NN	B-NP	O
HTN	HTN	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
Sarcoid	Sarcoid	JJ	I-NP	O
Left	Left	NN	I-NP	O
Breast	Breast	NN	I-NP	O
CA	CA	NN	I-NP	O
-	-	HYPH	B-NP	O
s/p	s/p	NN	I-NP	O
lumpect	lumpect	NN	I-NP	O
and	and	CC	I-NP	O
XRT/Adria	XRT/Adria	NN	I-NP	O
-	-	HYPH	B-NP	O
'84	'84	CD	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
?	?	.	O	O

GI	GI	NN	B-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
pain	pain	NN	I-NP	O
dvt	dvt	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
unspecified	unspecified	JJ	I-NP	O
or	or	CC	I-NP	O
generalized	generalize	VBN	I-NP	O
OA	OA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypothyroid	hypothyroid	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Midline	Midline	NNP	I-NP	O
placed	place	VBD	B-VP	O
on	on	IN	B-PP	O
4/30	4/30	CD	B-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
draws	draw	NNS	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
work	work	VB	I-VP	O
.	.	.	O	O

Midline	Midline	NN	B-NP	O
taken	take	VBN	B-VP	O
out	out	RP	B-PRT	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
61	61	CD	B-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
dilated	dilated	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
chemo	chemo	NN	I-NP	O
and	and	CC	I-NP	O
XRT	XRT	NN	I-NP	O
for	for	IN	B-PP	O
Breast	Breast	NN	B-NP	O
CA	CA	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
cough	cough	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
SOB	SOB	NN	I-NP	O
x	x	NN	I-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
DOE	DOE	NNP	B-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
pt	pt	NN	I-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
1	1	CD	B-NP	O
block	block	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
with	with	IN	B-PP	O
walker	walker	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
before	before	IN	B-PP	O
DOE	DOE	NNP	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
DOE	DOE	NNP	B-NP	O
after	after	IN	B-PP	O
1/2	1/2	CD	B-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
CP	CP	NN	B-NP	B-DNA
.	.	.	O	O

Pt	Pt	NN	B-NP	O
reports	report	NNS	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	I-NP	O
PND	PND	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
with	with	IN	B-PP	O
Abd	Abd	NNP	B-NP	O
CT	CT	NNP	I-NP	O
,	,	,	O	O
U/S	U/S	NNP	B-NP	O
showing	show	VBG	B-VP	O
sludge	sludge	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
Hx	Hx	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
Alk	Alk	NNP	I-NP	B-protein
Phos	Phos	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
abd	abd	NN	B-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
increased	increase	VBN	B-NP	O
bloating	bloating	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
increased	increase	VBN	I-NP	O
leg	leg	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
reports	report	NNS	B-NP	O
increased	increase	VBD	B-VP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
of	of	IN	B-PP	O
L	L	NN	B-NP	B-protein
arm	arm	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
wheezing	wheezing	NN	B-NP	O
without	without	IN	B-PP	O
increased	increase	VBN	B-NP	O
O2	O2	NN	I-NP	O
need	need	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
sick	sick	JJ	I-NP	O
contacts	contact	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
PE	PE	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T97	T97	NN	B-NP	O
.8	.8	CD	I-NP	O
HR73	HR73	NN	I-NP	O
BP113/71	BP113/71	NN	I-NP	O
RR18	RR18	NN	I-NP	O
O2Sat	O2Sat	NN	I-NP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
oropharynx	oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
CV	CV	NN	I-NP	I-protein
:	:	:	O	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
1/6	1/6	CD	B-NP	O
SEM	SEM	NNP	I-NP	O
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
ant	ant	JJ	B-ADJP	O
.	.	.	O	O

endexp	endexp	NN	B-NP	O
wheezes	wheeze	VBZ	B-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
mild	mild	JJ	B-NP	O
tenderness	tenderness	NN	I-NP	O
in	in	IN	B-PP	O
epigastrium	epigastrium	NN	B-NP	O
,	,	,	O	O
RUQ	RUQ	NN	B-NP	B-protein
,	,	,	O	O
distended	distend	VBD	B-VP	O
Ext	Ext	NNP	B-NP	O
:	:	:	O	O
Venous	Venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
arm	arm	NN	I-NP	O
larger	large	JJR	B-ADJP	O
than	than	IN	B-PP	O
R	R	NN	B-NP	B-protein
arm	arm	NN	I-NP	I-protein
*****	*****	SYM	B-NP	I-protein
Tests	Test	NNPS	I-NP	O
:	:	:	O	O
ALK	ALK	NN	B-NP	O
Phos	Phos	NN	I-NP	O
:	:	:	O	O
627	627	CD	B-NP	O
ALT	ALT	NN	I-NP	O
:	:	:	O	O
71	71	CD	B-NP	O
AST	AST	NN	I-NP	O
:	:	:	O	O
65	65	CD	B-NP	O
Card	Card	NNP	I-NP	O
Enzymes	Enzymes	NNP	I-NP	O
:	:	:	O	O
neg	neg	NN	B-NP	O
WBC	WBC	NN	I-NP	O
:	:	:	O	O
6.4	6.4	CD	B-NP	O
UA	UA	NNP	I-NP	O
:	:	:	O	O
1.011	1.011	CD	B-NP	O
,	,	,	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
prot	prot	NN	I-NP	O
,	,	,	O	O
5-10WBC	5-10WBC	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
bact	bact	NN	I-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
LLL	LLL	NN	B-NP	O
opacity	opacity	NN	I-NP	O
,	,	,	O	O
seen	see	VBN	B-VP	O
best	well	RBS	B-ADVP	O
on	on	IN	B-PP	O
lateral	lateral	JJ	B-NP	O
view	view	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
prolonged	prolong	VBN	B-NP	O
PR	PR	NN	I-NP	B-protein
,	,	,	O	O
q	q	NN	B-NP	O
in	in	IN	B-PP	O
AVL	AVL	NN	B-NP	O
,	,	,	O	O
flat	flat	JJ	B-NP	O
Ts	T	NNS	I-NP	O
laterally	laterally	RB	B-ADVP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
5/26	5/26	CD	B-NP	O
RUQ	RUQ	NNP	I-NP	O
US	US	NNP	I-NP	O
:	:	:	O	O
sludge	sludge	NN	B-NP	O
,	,	,	O	O
gall	gall	NN	B-NP	O
bladder	bladder	NN	I-NP	O
wall	wall	NN	I-NP	O
thickened	thicken	VBD	B-VP	O
8mm	8mm	CD	B-NP	O
,	,	,	O	O
neg	neg	NN	B-NP	O
sonographic	sonographic	JJ	I-NP	O
Murphy	Murphy	NNP	I-NP	O
's	's	POS	B-NP	O
sign	sign	NN	I-NP	O
,	,	,	O	O
B/L	B/L	NN	B-NP	O
small	small	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
1/9	1/9	CD	I-NP	O
Echo	Echo	NNP	I-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LV	LV	NN	B-NP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
mod	mod	NN	B-NP	O
dilated	dilate	VBN	B-VP	O
at	at	IN	B-PP	O
4.2	4.2	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
RWMA	RWMA	NNP	I-NP	O
,	,	,	O	O
mod-severe	mod-severe	JJ	B-NP	O
MR	MR	NN	I-NP	O
4/20	4/20	CD	I-NP	O
Abd	Abd	NNP	I-NP	O
U/S	U/S	NNP	I-NP	O
:	:	:	O	O
sludge	sludge	NN	B-NP	O
in	in	IN	B-PP	O
gallbladder	gallbladder	NN	B-NP	O
1/9	1/9	CD	I-NP	O
Abd	Abd	NN	I-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
Ascites	Ascites	NN	B-NP	O
1/9	1/9	CD	I-NP	O
PE	PE	NN	I-NP	O
protocol	protocol	NN	I-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
mild	mild	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
bilat	bilat	NN	B-NP	O
.	.	.	O	O

effusions	effusion	NNS	B-NP	O
,	,	,	O	O
anasarca	anasarca	NN	B-NP	O
**********************************************************************	**********************************************************************	SYM	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
61F	61F	NN	B-NP	O
with	with	IN	B-PP	O
LLL	LLL	NN	B-NP	O
PNA	PNA	NN	I-NP	O
and	and	CC	O	O
CHF	CHF	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
po	po	NN	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
for	for	IN	B-PP	O
LLL	LLL	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
course	course	NN	I-NP	O
and	and	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
vitals	vital	NNS	I-NP	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
sats	sat	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
HX	HX	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
weight	weight	NN	I-NP	O
227lbs	227lb	VBZ	B-VP	O
2/30/05	2/30/05	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
dry	dry	JJ	I-NP	B-protein
weight	weight	NN	I-NP	I-protein
~	~	NN	I-NP	I-protein
200	200	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
100mg	100mg	CD	I-NP	O
bid	bid	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
given	give	VBN	I-NP	O
po	po	NN	I-NP	O
lasix	lasix	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
of	of	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-VP	O
200bid	200bid	VB	I-VP	O
x	x	NN	B-NP	O
2	2	CD	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

Then	Then	RB	B-ADVP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
placed	place	VBD	B-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
and	and	CC	I-NP	O
zaroxyln	zaroxyln	NN	I-NP	B-protein
5mg	5mg	NN	I-NP	I-protein
po	po	NN	I-NP	I-protein
BID	BID	NNP	I-NP	O
x	x	CC	O	O
6	6	CD	B-NP	O
doses	dose	NNS	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

Lytes	Lyte	NNS	B-NP	O
closely	closely	RB	B-VP	O
monitored	monitor	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
draw	draw	VB	I-VP	O
blood	blood	NN	B-NP	O
from	from	IN	B-PP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
access	access	NN	I-NP	O
.	.	.	O	O

Followed	Follow	VBN	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
D/C	D/C	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
breathing	breathing	NN	I-NP	O
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ambulating	ambulate	VBG	I-VP	O
with	with	IN	B-PP	O
walker	walker	NN	B-NP	O
@	@	VBD	B-VP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
still	still	RB	B-ADVP	O
had	have	VBD	B-VP	O
BLE	BLE	NN	B-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Hx	Hx	NN	B-NP	O
of	of	IN	B-PP	O
gallbladder	gallbladder	NN	B-NP	O
sludge	sludge	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
RUQ	RUQ	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
w/u	w/u	NN	B-NP	O
with	with	IN	B-PP	O
CT	CT	NN	B-NP	B-protein
and	and	CC	O	O
US	US	NNP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
pt	pt	NN	B-NP	O
not	not	RB	O	O
surgical	surgical	JJ	B-NP	O
candidate	candidate	NN	I-NP	O
.	.	.	O	O

RUQ	RUQ	NN	B-NP	O
US	US	NNP	I-NP	O
showed	show	VBD	B-VP	O
just	just	RB	B-NP	O
sludge	sludge	NN	I-NP	O
,	,	,	O	O
gallbladder	gallbladder	NN	B-NP	O
wall	wall	NN	I-NP	O
thickened	thicken	VBD	B-VP	O
8mm	8mm	NN	B-NP	O
,	,	,	O	O
neg	neg	NN	B-NP	O
sonographic	sonographic	JJ	I-NP	O
murphy	murphy	NN	I-NP	O
's	's	POS	B-NP	O
sign	sign	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Rheum	Rheum	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
2/3	2/3	CD	I-NP	I-protein
pt	pt	JJ	I-NP	I-protein
c/o	c/o	NN	I-NP	I-protein
right	right	JJ	I-NP	I-protein
thumb	thumb	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
thumb	thumb	NN	I-NP	O
was	be	VBD	B-VP	O
red	red	JJ	B-ADJP	O
,	,	,	O	O
warm	warm	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
painful	painful	JJ	B-ADJP	O
to	to	TO	B-VP	O
touch	touch	VB	I-VP	O
at	at	IN	B-PP	O
joint	joint	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
h/o	h/o	NN	B-NP	O
gout	gout	NN	I-NP	O
-	-	HYPH	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
motrin	motrin	NN	B-NP	O
TID	TID	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Endo	Endo	AFX	B-NP	B-protein
-	-	HYPH	I-NP	O
BS	BS	NN	B-NP	O
were	be	VBD	B-VP	O
high	high	JJ	B-ADJP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
and	and	CC	I-NP	O
insulin	insulin	NN	I-NP	B-protein
was	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
appropriately	appropriately	RB	B-ADVP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	I-VP	O
60mg	60mg	VB	I-VP	O
QHS	QHS	NN	B-NP	B-protein
and	and	CC	I-NP	O
novolog	novolog	NN	I-NP	O
8u	8u	NN	I-NP	O
QAC	QAC	NN	I-NP	O
and	and	CC	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
d/c	d/c	NN	B-NP	O
'd	'd	MD	B-VP	O
home	home	VB	I-VP	O
on	on	IN	B-PP	O
lantus	lantus	NN	B-NP	O
60u	60u	NN	I-NP	O
QHS	QHS	NN	I-NP	O
with	with	IN	B-PP	O
novolog	novolog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Heme	Heme	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
5mg	5mg	NN	I-NP	O
po	po	NN	I-NP	O
QD	QD	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
on	on	IN	B-PP	O
10/3	10/3	CD	O	O
Follow	Follow	NNP	O	O
up	up	IN	B-SBAR	O
INR	INR	NNP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
2/17	2/17	CD	B-NP	O
INR	INR	NN	I-NP	O
on	on	IN	B-PP	O
2/3	2/3	NN	B-NP	O
was	be	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Primary	Primary	JJ	B-NP	O
care	care	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
lytes	lyte	NNS	B-NP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

INR	INR	NN	B-NP	O
checks	check	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
by	by	IN	B-PP	O
RMC	RMC	NN	B-NP	B-protein
and	and	CC	I-NP	O
coumadin	coumadin	NN	I-NP	O
dosing	dosing	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
into	into	IN	B-PP	O
Ak	Ak	NNP	B-NP	O
Heim	Heim	NNP	I-NP	O
pharmacy	pharmacy	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Monitor	Monitor	NN	B-NP	O
weight	weight	NN	I-NP	O
2x/week	2x/week	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

VNA	VNA	NN	B-NP	O
arranged	arrange	VBD	B-VP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
to	to	TO	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
on	on	IN	B-PP	O
8/7	8/7	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
goal	goal	NN	I-NP	B-protein
2-3	2-3	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
sent	send	VBD	B-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
5mg	5mg	NN	I-NP	O
po	po	NN	I-NP	O
QHS	QHS	NNP	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
results	result	NNS	I-NP	O
interepreted	intereprete	VBN	B-VP	O
by	by	IN	B-PP	O
NH	NH	NN	B-NP	O
and	and	CC	I-NP	O
coumadin	coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
calle	calle	JJ	B-ADJP	O
into	into	IN	B-PP	O
A	A	NNP	B-NP	O
Larepitbrown	Larepitbrown	NNP	I-NP	O
Lyoco	Lyoco	NNP	I-NP	O
pharmacy	pharmacy	NN	I-NP	O
807-526-4223	807-526-4223	CD	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
100mg	100mg	CD	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
and	and	CC	I-NP	O
monitor	monitor	NN	I-NP	O
weights	weight	NNS	I-NP	O
2x/week	2x/week	VBP	B-VP	O
.	.	.	O	O

Keep	Keep	NN	B-NP	O
legs	leg	NNS	I-NP	O
elevated	elevate	VBN	B-VP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
reduce	reduce	VB	I-VP	O
swelling	swelling	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
make	make	VB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Danahy	Danahy	NNP	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
blood	blood	NN	B-NP	O
work	work	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Take	Take	VB	B-VP	O
motrin	motrin	NN	B-NP	O
600mg	600mg	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
thumb	thumb	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Once	Once	IN	B-SBAR	O
pain	pain	NN	B-NP	O
resolves	resolve	NNS	I-NP	O
,	,	,	O	O
resume	resume	VB	B-VP	O
taking	take	VBG	I-VP	O
your	your	PRP$	B-NP	O
allopurinol	allopurinol	NN	I-NP	O
100mg	100mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
gout	gout	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
lantus	lantus	NN	I-NP	O
insulin	insulin	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
60units	60unit	NNS	B-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
continue	continue	VB	I-VP	O
your	your	PRP$	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
as	as	IN	B-PP	O
usual	usual	JJ	B-ADJP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
need	need	VB	B-VP	O
procrit	procrit	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
for	for	IN	B-PP	O
bloodwork	bloodwork	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Contact	Contact	VB	B-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
or	or	CC	O	O
come	come	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
fever	fever	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
FLY	FLY	NNP	B-NP	O
,	,	,	O	O
RENATO	RENATO	NNP	B-NP	O
T.	T.	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MN92	MN92	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/13/05	1/13/05	CD	I-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
29	29	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

